Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Wysoglad, Hubert [1 ,2 ]
Krawczyk, Katarzyna [2 ,3 ]
Ochrem, Bogdan [2 ,3 ]
Madry, Krzysztof [1 ]
Drozd-Sokolowska, Joanna [1 ]
Sacha, Tomasz [2 ,3 ]
Basak, Grzegorz [1 ]
机构：
[1] Med Univ Warsaw, Dept Hematol Transplantol & Internal Med, Warsaw, Poland
[2] Univ Hosp Krakow, Dept Hematol, Krakow, Poland
[3] Jagiellonian Univ Med Coll, Dept Hematol, Krakow, Poland
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
acute myeloid leukemia; azacitidine; venetoclax; real-world evidence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-384
引用
收藏
页码：S294 / S294
页数：1
相关论文
共 50 条
  • [1] Oral azacitidine maintenance after intensive chemotherapy versus venetoclax and azacitidine: real world outcomes in newly diagnosed acute myeloid leukemia
    Mims, Alice
    Xie, Zhuoer
    Potluri, Ravi
    Rotter, David
    Chevli, Manoj
    Prebet, Thomas
    Gaugler, Lona
    Strocchia, Maria
    Vasconcelos, Alberto
    Sieluk, Jan
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 479 - 487
  • [2] Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience
    Baba, Yuta
    Hida, Noriko
    Sambe, Takehiko
    Abe, Maasa
    Kabasawa, Nobuyuki
    Sakai, Hirotaka
    Yoshimura, Kiyoshi
    Fukuda, Tetsuya
    ANTICANCER RESEARCH, 2024, 44 (05) : 2003 - 2007
  • [3] Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy
    Acker, Fabian
    Chromik, Joerg
    Tiedjen, Emily
    Wolf, Sebastian
    Vischedyk, Jonas B.
    Makowka, Philipp
    Enssle, Julius C.
    Kouidri, Khouloud
    Sebastian, Martin
    Steffen, Bjoern
    Oellerich, Thomas
    Serve, Hubert
    Neubauer, Andreas
    Schaefer, Jonas A.
    Bittenbring, Joerg T.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (05) : 623 - 630
  • [4] Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
    Short, Nicholas J.
    Wierzbowska, Agnieszka
    Cluzeau, Thomas
    Laribi, Kamel
    Recher, Christian
    Czyz, Jaroslaw
    Ochrem, Bogdan
    Ades, Lionel
    Gallego-Hernanz, Maria Pilar
    Heiblig, Mael
    Audisio, Ernesta
    Zarzycka, Ewa
    Li, Shuli
    Ferenc, Nicholas
    Yeh, Tammie
    Faller, Douglas V.
    Sedarati, Farhad
    Papayannidis, Cristina
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 458 - 468
  • [5] A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia
    Hu, Rong-Hua
    Su, Li
    Lan, Xiao-Xi
    Chang, Xiao-Li
    Hui, Wu-Han
    Guo, Yi-Xian
    Zhao, Hong
    Zhang, Yue
    Sun, Wan-Ling
    ANTI-CANCER DRUGS, 2023, 34 (03) : 344 - 350
  • [6] Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy
    Richard-Carpentier, Guillaume
    DiNardo, Courtney D.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [7] Combining azole antifungals with venetoclax plus azacitidine in patients with newly diagnosed acute myeloid leukemia
    Zhong, Xushu
    Wang, Jia
    Dai, Yang
    Huang, Xiaoou
    Liu, Jiazhuo
    Xiang, Bing
    Ma, Hongbing
    HEMATOLOGY, 2024, 29 (01)
  • [8] Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Alary, Anne-Sophie
    Saillard, Colombe
    Hicheri, Yosr
    Mohty, Bilal
    Rey, Jerome
    D'Incan, Evelyne
    Charbonnier, Aude
    Villetard, Ferdinand
    Maisano, Valerio
    Lombardi, Laura
    Ittel, Antoine
    Mozziconacci, Marie-Joelle
    Gelsi-Boyer, Veronique
    Vey, Norbert
    CANCERS, 2022, 14 (08)
  • [9] Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Lee, Kyoo-Hyung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05) : 290 - +
  • [10] Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Yamamoto, Kazuhito
    Shinagawa, Atsushi
    DiNardo, Courtney D.
    Pratz, Keith W.
    Ishizawa, Kenichi
    Miyamoto, Toshihiro
    Komatsu, Norio
    Nakashima, Yasuhiro
    Yoshida, Chikashi
    Fukuhara, Noriko
    Usuki, Kensuke
    Yamauchi, Takahiro
    Asada, Noboru
    Asou, Norio
    Choi, Ilseung
    Miyazaki, Yasushi
    Honda, Hideyuki
    Okubo, Sumiko
    Kurokawa, Misaki
    Zhou, Ying
    Zha, Jiuhong
    Potluri, Jalaja
    Matsumura, Itaru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (01) : 29 - 38
12345